Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARVN Arvinas Holding Company LLC

交易中 03-19 09:41:16 EDT

8.55

+0.13

+1.57%

最高8.58	最低8.40	成交量4.19万
今开8.42	昨收8.42	日振幅2.08%
总市值5.88亿	流通市值4.59亿	总股本6,877万
成交额35.41万	换手率0.08%	流通股本5,369万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARVN","market":"US","secType":"STK","nameCN":"Arvinas Holding Company LLC","latestPrice":8.5519,"timestamp":1742391671155,"preClose":8.42,"halted":0,"volume":41889,"delay":0,"floatShares":53692300,"shares":68771867,"eps":-2.766342,"marketStatus":"交易中","change":0.1319,"latestTime":"03-19 09:41:16 EDT","open":8.42,"high":8.5755,"low":8.4,"amount":354124.4327085,"amplitude":0.020843,"askPrice":8.58,"askSize":220,"bidPrice":8.52,"bidSize":316,"shortable":3,"etf":0,"ttmEps":-2.766342,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1742414400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538020800000,"exchange":"NASDAQ","adjPreClose":8.42,"preHourTrading":{"tag":"盘前","latestPrice":8.3831,"preClose":8.42,"latestTime":"09:27 EDT","volume":974,"amount":8223.894976,"timestamp":1742390829439},"postHourTrading":{"tag":"盘后","latestPrice":8.3622,"preClose":8.42,"latestTime":"19:46 EDT","volume":52694,"amount":443120.4433,"timestamp":1742341590734},"volumeRatio":0.333136,"impliedVol":1.2046,"impliedVolPercentile":0.852},"requestUrl":"/m/hq/s/ARVN","defaultTab":"news","newsList":[{"id":"2518745334","title":"辉瑞乳腺癌新药Vepdegestrant研究喜忧参半，授权方Arvinas股价暴跌40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745334","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518745334?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:59","pubTimestamp":1741697953,"startTime":"0","endTime":"0","summary":"辉瑞公司的下一代乳腺癌治疗药物 vepdegestrant 在最后阶段的研究中取得了好坏参半的结果，未能延缓所有患者的癌症进展，但达到了针对具有特定基因突变的亚组患者的目标。","market":"sg","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260559.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["PFE","SG9999013999.USD","LU0225284248.USD","SGXZ57979304.SGD","BK4007","LU0058720904.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","BK4533","IE00B19Z3B42.SGD","LU0122379950.USD","SG9999003800.SGD","LU0225771236.USD","LU0306806265.USD","LU0985481810.HKD","LU0456855351.SGD","BK4588","BK4592","LU0234572021.USD","BK4568","LU0306807586.USD","LU0321505439.SGD","LU1023059063.AUD","IE00B19Z3581.USD","BK4550","LU0289739699.SGD","LU1057294990.SGD","LU1894683348.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU1883839398.USD","BK4581","SG9999002232.USD","BK4534","SG9999001176.SGD","LU0321505868.SGD","LU1894683264.USD","IE0002270589.USD","ARVN","BK4585","LU1066051498.USD","LU1066053197.SGD","LU0868494617.USD","SG9999002224.SGD","SG9999001176.USD","BK4599","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2518495206","title":"Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报17.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518495206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518495206?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:13","pubTimestamp":1741630432,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时13分，Arvinas, Inc.股票出现异动，股价急速下挫5.14%。截至发稿，该股报17.34美元/股，成交量57.7109万股，换手率0.84%，振幅6.04%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2517693254","title":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517693254","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517693254?lang=zh_cn&edition=full","pubTime":"2025-03-08 05:50","pubTimestamp":1741384237,"startTime":"0","endTime":"0","summary":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08055048605286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2517194729","title":"Arvinas, Inc.盘中异动 下午盘急速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517194729?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:38","pubTimestamp":1741289911,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时38分，Arvinas, Inc.股票出现异动，股价急速拉升5.20%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2517493229","title":"Arvinas, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517493229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517493229?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:48","pubTimestamp":1741189728,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时48分，Arvinas, Inc.股票出现异动，股价快速上涨5.12%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234848963aef75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234848963aef75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2516654586","title":"Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报16.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516654586?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:10","pubTimestamp":1741025417,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时10分，Arvinas, Inc.股票出现波动，股价急速下跌5.14%。截至发稿，该股报16.79美元/股，成交量40.2474万股，换手率0.59%，振幅6.64%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021017abe6739c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021017abe6739c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2514874323","title":"Arvinas, Inc.盘中异动 大幅拉升5.08%报18.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514874323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514874323?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:28","pubTimestamp":1740673739,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时28分，Arvinas, Inc.股票出现波动，股价急速上涨5.08%。截至发稿，该股报18.01美元/股，成交量24.8737万股，换手率0.36%，振幅5.81%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228002859a25696fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228002859a25696fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2514510868","title":"Arvinas, Inc.盘中异动 临近午盘急速跳水5.09%报16.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514510868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514510868?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:59","pubTimestamp":1740589154,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时59分，Arvinas, Inc.股票出现波动，股价大幅下跌5.09%。截至发稿，该股报16.77美元/股，成交量43.8865万股，换手率0.64%，振幅6.15%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022700591496316adf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022700591496316adf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2514464390","title":"Arvinas, Inc.盘中异动 临近收盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514464390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514464390?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:31","pubTimestamp":1740515492,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时31分，Arvinas, Inc.股票出现波动，股价急速拉升5.01%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022604313398928e70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022604313398928e70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2513041727","title":"Arvinas, Inc.盘中异动 股价大跌5.21%报16.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513041727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513041727?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:51","pubTimestamp":1740408671,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时51分，Arvinas, Inc.股票出现波动，股价大幅下挫5.21%。截至发稿，该股报16.85美元/股，成交量12.1291万股，换手率0.18%，振幅5.06%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225112a2521989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225112a2521989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2513219311","title":"Arvinas, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513219311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513219311?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:45","pubTimestamp":1740163510,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时45分，Arvinas, Inc.股票出现波动，股价急速下挫5.01%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024510988e1498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024510988e1498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2512165363","title":"Arvinas, Inc.盘中异动 快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165363?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889480,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Arvinas, Inc.股票出现波动，股价快速上涨5.30%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223800abd3b0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223800abd3b0a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4007","ARVN"],"gpt_icon":0},{"id":"2511692603","title":"Arvinas, Inc.2024财年实现净利润-1.99亿美元，同比增加45.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692603","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511692603?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548841,"startTime":"0","endTime":"0","summary":"2月15日，Arvinas, Inc.公布财报，公告显示公司2024财年净利润为-1.99亿美元，同比增加45.78%；其中营业收入为2.63亿美元，同比增加235.03%，每股基本收益为-2.77美元。从资产负债表来看，Arvinas, Inc.总负债5.30亿美元，其中短期债务2.00百万美元，资产负债比为2.06，流动比率为4.64。机构评级：截至2025年2月15日，当前有18家机构对Arvinas, Inc.目标价做出预测，其中目标均价为63.22美元，其中最低目标价为32.00美元，最高目标价为110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000115abcf1aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000115abcf1aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN"],"gpt_icon":0},{"id":"1125823359","title":"异动解读 | Arvinas公司股价盘中大涨5.09%,分析师下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1125823359","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125823359?lang=zh_cn&edition=full","pubTime":"2025-02-12 22:50","pubTimestamp":1739371816,"startTime":"0","endTime":"0","summary":"生物制药公司Arvinas(ARVN.US)今日盘中股价大涨5.09%,引起了市场广泛关注。\n\n消息面上,高盛分析师下调了Arvinas目标股价,由63美元调整至51美元,但维持该公司的买入评级。这或许是导致该股盘中大涨的主要原因。\n\n分析师下调股价目标通常会令公司股价面临一定压力。但在此次情况下,分析师维持了买入评级,或许体现出对公司长期前景的乐观评估,缓解了股价下跌的顾虑,反而引发了投资者的积极买盘。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Arvinas公司股价盘中大涨5.09%,分析师下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARVN"],"gpt_icon":0},{"id":"2510008379","title":"Stifel：维持Arvinas(ARVN.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至51.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510008379","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510008379?lang=zh_cn&edition=full","pubTime":"2025-02-12 21:12","pubTimestamp":1739365974,"startTime":"0","endTime":"0","summary":"Stifel：维持Arvinas(ARVN.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至51.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12211248121370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2510538773","title":"Arvinas, Inc.盘中异动 股价大跌5.11%报18.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510538773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510538773?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284601,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，Arvinas, Inc.股票出现异动，股价大幅下跌5.11%。截至发稿，该股报18.00美元/股，成交量6.0754万股，换手率0.09%，振幅5.27%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112236429881be0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112236429881be0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007","OCEA","BK4139"],"gpt_icon":0},{"id":"1190616450","title":"Arvinas 2024年第四季度GAAP每股收益$(0.63)优于预期$(0.87)，销售额$59.20M低于预期$65.28M","url":"https://stock-news.laohu8.com/highlight/detail?id=1190616450","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190616450?lang=zh_cn&edition=full","pubTime":"2025-02-11 20:07","pubTimestamp":1739275622,"startTime":"0","endTime":"0","summary":"Arvinas报告季度每股亏损$，好于分析师一致预期的$，超出27.59%。相比去年同期每股亏损$，这是一个75.1%的增加。公司报告季度销售额为$59.20百万，低于分析师一致预期的$65.28百万，低了9.31%。以上内容来自Benzinga Earnings专栏，原文如下：Arvinas  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 27.59 percent. This is a 75.1 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $59.20 million which missed the analyst consensus estimate of $65.28 million by 9.31 percent.  This is a 237.35 p","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Arvinas 2024年第四季度GAAP每股收益$(0.63)优于预期$(0.87)，销售额$59.20M低于预期$65.28M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARVN"],"gpt_icon":0},{"id":"2509287914","title":"Arvinas, Inc.盘中异动 快速上涨5.07%报18.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509287914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509287914?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:47","pubTimestamp":1738766876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时47分，Arvinas, Inc.股票出现波动，股价快速拉升5.07%。截至发稿，该股报18.97美元/股，成交量12.6521万股，换手率0.18%，振幅4.16%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522475696190c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020522475696190c3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KTTA","BK4139","ARVN"],"gpt_icon":0},{"id":"2508468794","title":"Arvinas, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508468794?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:05","pubTimestamp":1738681537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时05分，Arvinas, Inc.股票出现波动，股价大幅上涨5.20%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230537a2392ff9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230537a2392ff9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2508210141","title":"Arvinas, Inc.盘中异动 大幅下跌5.51%报16.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508210141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508210141?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:37","pubTimestamp":1738593441,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时37分，Arvinas, Inc.股票出现波动，股价急速跳水5.51%。截至发稿，该股报16.64美元/股，成交量4.0499万股，换手率0.06%，振幅3.52%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032237219616fc90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032237219616fc90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arvinas.com","stockEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":-0.5401},{"period":"3month","weight":-0.5476},{"period":"6month","weight":-0.6711},{"period":"1year","weight":-0.8023},{"period":"ytd","weight":-0.5608}],"compareEarnings":[{"period":"1week","weight":0.0092},{"period":"1month","weight":-0.0798},{"period":"3month","weight":-0.0431},{"period":"6month","weight":-0.0174},{"period":"1year","weight":0.0939},{"period":"ytd","weight":-0.0428}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arvinas, Inc.于2013年2月根据特拉华州法律成立。该公司是一家生物制药公司，致力于通过发现、开发和商业化治疗降低致病蛋白质来改善患有衰弱和危及生命的疾病的患者的生活。该公司使用他们的专有技术平台来设计针对嵌合体或PROTAC的蛋白水解，这些嵌合体旨在利用人体自身的天然蛋白质处理系统来选择性地和有效地降解和去除致病蛋白质。Arvinas Holding Company，LLC相信他们的靶向蛋白质降解方法是一种新的治疗方式，可能提供优于现有方式的独特优势，包括传统的小分子疗法和基于基因的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.025374},{"month":2,"riseRate":0.571429,"avgChangeRate":0.011057},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.176439},{"month":4,"riseRate":0.5,"avgChangeRate":0.050906},{"month":5,"riseRate":0.5,"avgChangeRate":-0.112391},{"month":6,"riseRate":0.833333,"avgChangeRate":0.011275},{"month":7,"riseRate":0.666667,"avgChangeRate":0.126111},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.076544},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.103315},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.018156},{"month":11,"riseRate":0.714286,"avgChangeRate":0.161248},{"month":12,"riseRate":0.571429,"avgChangeRate":0.407187}],"exchange":"NASDAQ","name":"Arvinas Holding Company LLC","nameEN":"Arvinas Holding Company LLC"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arvinas Holding Company LLC,ARVN,Arvinas Holding Company LLC股票,Arvinas Holding Company LLC股票老虎,Arvinas Holding Company LLC股票老虎国际,Arvinas Holding Company LLC行情,Arvinas Holding Company LLC股票行情,Arvinas Holding Company LLC股价,Arvinas Holding Company LLC股市,Arvinas Holding Company LLC股票价格,Arvinas Holding Company LLC股票交易,Arvinas Holding Company LLC股票购买,Arvinas Holding Company LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}